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FIGURE 1. A unicusp dysmorphic aortic valve with severe aortic stenosis (A) was repaired by removal of excessive fibrous tissue, commissurotomies, and
2 trigonal cusp extensions of autologous glutaraldehyde-treated pericardial patches (B). Recurrent overgrowths of the fibrous tissue occurred on the aortic
cusps, and the balloon valvuloplasty resulted in tear of the larger cusp, with severe aortic insufficiency (C). The tear was repaired with an autologous
glutaraldehyde-treated pericardial patch (D). LCA, Left coronary artery; RCA, right coronary artery.
Letters to the Editorrelative to Ross procedures during
recent years.5 With the exception of
exceedingly rare cases of severe aortic
valve endocarditis,all aortic valves can
be repaired in neonates and infants.
Neonates and infants with left ventric-
ular outflow tract obstruction who are
considered for the Ross-Konno proce-
dure are often better suited to univen-
tricular repair. Most importantly,
severe aortic insufficiency after failed
balloon dilatation is not an absolute
indication for the Ross procedure.
The following case report illustrates
this point. A 3-day-old girl (3.3 kg,
aortic valve annulus 4.7 mm)with crit-
ical aortic stenosis and severely
reduced left ventricular function un-
derwent aortic valve repair (Figure 1,
A and B). She was discharged with
normal left ventricular function and
was seen for aortic balloon dilatation
at 5 months of age (6 kg, aortic valve
annulus 8 mm) with mean gradient of
60 mm Hg and normal left ventricular
function. Aortic balloon dilatation re-
sulted in severe aortic insufficiency
and cardiac fibrillation. The patient
underwent emergency extracorporeal
membrane oxygenation support
through the neck vessels, and emer-
gency reoperative aortic valve repair
was performed (Figure 1,C andD).Af-
ter the operation, extracorporeal mem-
brane oxygenation was discontinued,The Journaland the neck vessels were repaired.
The patient is doing well at 1 year of
age (9 kg, aortic valve annulus 9
mm), with no aortic insufficiency and
mild stenosis.
We believe that Ross procedures
should be postponed beyond infancy,
ideally into adulthood if feasible.
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We appreciate the huge experience
recently published by Tan Tanny
and colleagues1 regarding the Ross
operation in 100 patients in a pediatric
population, confirming our results in
which greater mortality was observed
in neonates and infants.
For this reason, theyhave been trying
to switch the treatment from the
Ross procedure to aortic valve repair
in neonates and infants. We believe
that this could be a very good strategy
to follow, with 2 main observations.
First, the real benefit of aortic valve
conservative surgery can be evaluated
in depth only after 2 decades of
follow-up. Second, aortic repair
at a low patient weight will be a
very technically demanding operation
requiring a long learning curve.
Considering that the Melbourne
Centre is a leading institution in
such a field worldwide, we sincerely
appreciate their results.2 However, a
word of caution must be given,
because their numbers are not so
easily reproducible in most centers
without a specific commitment.ry c Volume 148, Number 1 363
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To the Editor:
We read with interest the article by
Santarpino and colleagues1 in which
they compared minimally invasive
aortic valve replacement with suture-
less valves with transcatheter aortic
valve implantation in a propensity-
matched cohort of 37 patients in
each group. They concluded that the
advantages of sutureless valves are
shorter procedural times (crossclamp
time of 38.9  13.7 minutes and car-
diopulmonary bypass time of 68.9 
20.2 minutes) and less paravalvular
leak relative to transcatheter aortic
valve implantation. They reported
a high incidence of permanent
pacemaker implantation (10.8%).
The incidence of paravalvular leak
with sutureless valves in the literature
varies from 2% to 15%.2,3 Santarpino
and colleagues attributed their low
paravalvular leak to ‘‘moderate
decalcification.’’
To produce superior results to trans-
catheter aortic valve implantation in
high-risk patients, first, zero paravalvu-
lar leak with fairly large prosthesis size
and effective orifice area and low pace-
maker implantation rate are required.
These conditions will not be met by364 The Journal of Thoracic and Cmoderate or even less decalcification
of the annulus. Second, cardiopulmo-
nary bypass is the key contraindication
to surgery for elderly patients, particu-
larly those with pulmonary dysfunc-
tion, not the duration of bypass and
clamp time. The bypass and clamp
times achieved by Santarpino and
colleagues1 with sutureless valves are
not too different from our own
propensity-matched series4 of 205 pa-
tients (crossclamp time of 49 minutes
with a range of 42-63 minutes and car-
diopulmonary bypass time of 71 mi-
nutes with a range of 59-94 minutes)
in which we used minimally invasive
incision but with valve sutures. Even
in reoperative minimal access aortic
valve replacement (with or without
concomitant procedures)with standard
suturing techniques, fairly short cross-
clamp times can be achieved.5
Very good applications of suture-
less valves would be for a patient
with a failing homograft with a
severely calcified annulus and also
for difficult reoperations when the
annulus has been destroyed.
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To the Editor:
We wish to thank Dr Soppa for his
comments on our study published in
the February issue of the Journal.1
His contribution helps to keep alive
the debate on the most appropriate
treatment strategy for high-risk
patients with severe aortic stenosis.
We acknowledge that our study had
several limitations, as was stated in
the discussion, including a lack of
randomization and failure to consider
relevant factors such as patient frailty.
The main advantage of sutureless
aortic valve replacement versus trans-
catheter aortic valve implantation is
the lower or nil rate of paravalvular
leak, which has also been confirmed
by other investigators,2 and not
a shorter cardiopulmonary bypass
time, such as suggested by Dr Soppa.
This finding is of particular relevance
given the well-recognized correlation
between even mild paravalvular
leakage and increased mortality
during follow-up.3 We congratulate
Soppa and colleagues for the results
they presented at the last Society
for Cardiothoracic Surgery Congress
showing similar aortic crossclamp
times in minimally invasive surgery
using a stented prosthesis. Recently,
we demonstrated that in patients
undergoing isolated aortic valve
replacement, the aortic crossclamp
times were reduced by 40% when a
minimally invasive approach was
